Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repligen Co. (NASDAQ:RGEN – Get Rating) shares traded up 4.3% during mid-day trading on Wednesday . The stock traded as high as $178.26 and last traded at $177.66. 322,077 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 547,335 shares. The stock had previously closed at $170.39. Analysts […]
Shares of Repligen Co. (NASDAQ:RGEN – Get Rating) have received a consensus rating of “Moderate Buy” from the ten brokerages that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have assigned a buy recommendation to the […]
Repligen Co. (NASDAQ:RGEN – Get Rating) has earned a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The average […]
Comerica Bank boosted its stake in Repligen Co. (NASDAQ:RGEN – Get Rating) by 11.7% in the fourth quarter, HoldingsChannel reports. The firm owned 117,682 shares of the biotechnology company’s stock after buying an additional 12,309 shares during the period. Comerica Bank’s holdings in Repligen were worth $21,850,000 as of its most recent SEC filing. A […]
Inspire Investing LLC lifted its position in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 19.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,163 shares of the biotechnology company’s stock after purchasing an additional 1,320 shares during […]